News Events

Present at CTAD 2019

ADx NeuroSciences will be present at CTAD. You can reach us via mail to info@adxneurosciences.com

Previous PostADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.
Next PostADx receives funding from Bill Gates for developing blood biomarkers